Endocannabinoid Regulation of Acute and Protracted Nicotine Withdrawal: Effect of FAAH Inhibition
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Evidence shows that the endocannabinoid system modulates the addictive properties of nicotine. In the present study, we hypothesized that spontaneous withdrawal resulting from removal of chronically implanted transdermal nicotine patches is regulated by the endocannabinoid system. A 7-day nicotine dependence procedure (5.2 mg/rat/day) elicited occurrence of reliable nicotine abstinence symptoms in Wistar rats. Somatic and affective withdrawal signs were observed at 16 and 34 hours following removal of nicotine patches, respectively. Further behavioral manifestations including decrease in locomotor activity and increased weight gain also occurred during withdrawal. Expression of spontaneous nicotine withdrawal was accompanied by fluctuation in levels of the endocannabinoid anandamide (AEA) in several brain structures including the amygdala, the hippocampus, the hypothalamus and the prefrontal cortex. Conversely, levels of 2-arachidonoyl-sn-glycerol were not significantly altered. Pharmacological inhibition of fatty acid amide hydrolase (FAAH), the enzyme responsible for the intracellular degradation of AEA, by URB597 (0.1 and 0.3 mg/kg, i.p.), reduced withdrawal-induced anxiety as assessed by the elevated plus maze test and the shock-probe defensive burying paradigm, but did not prevent the occurrence of somatic signs. Together, the results indicate that pharmacological strategies aimed at enhancing endocannabinoid signaling may offer therapeutic advantages to treat the negative affective state produced by nicotine withdrawal, which is critical for the maintenance of tobacco use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat
Pellow, S., Chopin, P., File, S. E., & Briley, M. (1985) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(85)90031-7 · Cited by 5,822
The molecular logic of endocannabinoid signalling
Piomelli, D. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1247 · Cited by 1,957 · cited 2×
“To test the hypothesis that nicotine abstinence is associated with alterations in endocannabinoid levels, in the present work the contents of AEA and 2-AG were examined in brain structures that are known to play a role in the regulation of negative reinforcement and drug withdrawal symptoms and that express elevated e…”
BackgroundSelf-citationThe endogenous cannabinoid system controls extinction of aversive memories
Marsicano, G., Wotjak, C. T., Azad, S. C., Bisogno, T., Rammes, G., Cascio, M. G., Hermann, H., Tang, J., Hofmann, C., Zieglgänsberger, W., et al. (2002) · Nature · doi:10.1038/nature00839 · Cited by 1,728 · cited 1×
“On the other hand, the endocannabinoid system has been suggested to act as an anti-stress system [70,71].”
BackgroundModulation of anxiety through blockade of anandamide hydrolysis
Kathuria, S., Gaetani, S., Fegley, D., Valiño, F., Duranti, A., Tontini, A., Mor, M., Tarzia, G., Rana, G. L., Calignano, A., et al. (2003) · Nature Medicine · doi:10.1038/nm803 · Cited by 1,293 · cited 4×
“3 mg/kg) or vehicle was given 120 min prior the signs’ observation and locomotor performance, since FAAH inhibition by URB597 occurs rapidly (,15 minutes) and persists more than six hours [34,36].”
BackgroundMethodInfluentialSelf-citationDramatic decreases in brain reward function during nicotine withdrawal
Epping-Jordan, M. P., Watkins, S. S., Koob, G. F., & Markou, A. (1998) · Nature · doi:10.1038/30001 · Cited by 674
Pich, E., Lorang, M., Yeganeh, M., Rodriguez de Fonseca, F., Raber, J., Koob, G., & Weiss, F. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-08-05439.1995 · Cited by 565
Activation of Corticotropin-Releasing Factor in the Limbic System During Cannabinoid Withdrawal
Rodrı́guez de Fonseca, F., Carrera, M. R. A., Navarro, M., Koob, G. F., & Weiss, F. (1997) · Science · doi:10.1126/science.276.5321.2050 · Cited by 499
Symptoms of Tobacco Withdrawal: A Replication and Extension
Hughes, J. R. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810250054007 · Cited by 449
Fegley, D., Gaetani, S., Duranti, A., Tontini, A., Mor, M., Tarzia, G., & Piomelli, D. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.078980 · Cited by 427
Self-citationConditioned defensive burying: A new paradigm for the study of anxiolytic agents
Treit, D., Pinel, J. P. J., & Fibiger, H. C. (1981) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(81)90219-7 · Cited by 420 · cited 1×
“The shockprobe defensive burying test [40,41] was used as an additional measure for the assessment of anxiety-like behavior.”
MethodNicotinic receptors in the brain. Links between molecular biology and behavior
Picciotto, M. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00146-3 · Cited by 354
Rodent model of nicotine abstinence syndrome
Malin, D. H., Lake, J. R., Newlin-Maultsby, P., Roberts, L. K., Lanier, J. G., Carter, V. A., Cunningham, J. S., & Wilson, O. B. (1992) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(92)90408-8 · Cited by 334 · cited 8×
“Observers counted the frequency of signs on a standard checklist of nicotine abstinence signs, as previously described [11].”
BackgroundMethodInfluentialNeurobiology of the nicotine withdrawal syndrome
Kenny, P. J., & Markou, A. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00651-7 · Cited by 310 · cited 2×
“opioid peptides, serotonin and glutamate systems [5,21].”
BackgroundPatel, S., Roelke, C. T., Rademacher, D. J., & Hillard, C. J. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.03916.x · Cited by 297 · cited 2×
“Considering that elevated contents in hypothalamic AEA may take part to the regulation of neuroendocrine response to stress [70], it may be possible that dysregulation of the endocannabinoid system in this area may take part to alterations of hypothalamic-pituitary-adrenal axis activity associated to nicotine withdraw…”
BackgroundGeorge, O., Ghozland, S., Azar, M. R., Cottone, P., Zorrilla, E. P., Parsons, L. H., O'Dell, L. E., Richardson, H. N., & Koob, G. F. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707585104 · Cited by 245 · cited 1×
“CRH is thought to play a central role of the modulation of withdrawal from a variety of drugs including alcohol [65], cocaine [66], cannabis [67] and nicotine [68,69].”
BackgroundCharacterization of spontaneous and precipitated nicotine withdrawal in the mouse
Damaj, M. I., Kao, W., & Martin, B. R. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.054908 · Cited by 222 · cited 1×
“mice [14,15,16,17,18].”
Watkins, S. S., Stinus, L., Koob, G. F., & Markou, A. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35389-3 · Cited by 214 · cited 1×
“consumption in smokers [3,4,5].”
Hughes, J. (2007) · Nicotine & Tobacco Research · doi:10.1080/14622200701188927 · Cited by 173 · cited 1×
“gain, decreased heart rate and craving for tobacco [6,7,8].”
BackgroundMalin, D. H. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00699-2 · Cited by 167 · cited 2×
“In several studies including ours, it has been shown that somatic manifestations of nicotine withdrawal peak at about 16 h from nicotine exposure [11,12,46].”
BackgroundHaller, J., Barna, I., Barsvari, B., Gyimesi Pelczer, K., Yasar, S., Panlilio, L. V., & Goldberg, S. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1494-7 · Cited by 159
Cannich, A., Wotjak, C. T., Kamprath, K., Hermann, H., Lutz, B., & Marsicano, G. (2004) · Learning & Memory · doi:10.1101/lm.77904 · Cited by 130 · cited 1×
“Endocannabinoid extraction and analysis - Selected brain regions were punched from the frozen brains using a cryo-cut and cylindrical brain punchers (Fine Science tools, Foster City, CA, USA), as previously described [42].”
MethodHildebrand, B. E., Nomikos, G. G., Bondjers, C., Nisell, M., & Svensson, T. H. (1997) · Psychopharmacology · doi:10.1007/s002130050200 · Cited by 122
Helton, D. R., Tizzano, J. P., Monn, J. A., Schoepp, D. D., & Kallman, M. J. (1997) · Neuropharmacology · doi:10.1016/s0028-3908(97)00170-6 · Cited by 103 · cited 1×
“Previous studies in rats also showed heightened anxiety in the auditory startle reflex and social interaction tests in rats made dependent to nicotine [47,48,49].”
BackgroundTolerance to nicotine's effects in the elevated plus-maze and increased anxiety during withdrawal
Irvine, E. E., Cheeta, S., & File, S. E. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00449-4 · Cited by 88 · cited 1×
“Previous studies in rats also showed heightened anxiety in the auditory startle reflex and social interaction tests in rats made dependent to nicotine [47,48,49].”
BackgroundIncreased anxiety-like behavior in adult rats exposed to nicotine as adolescents
Slawecki, C. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(03)00093-5 · Cited by 87 · cited 1×
“The present findings confirm previous studies in adolescent rats where long-lasting effects on locomotor activity and anxietylike behaviors were described following chronic nicotine patch delivery [13,45].”
Result
Cited by
The endocannabinoid system and the brain.
Mechoulam, R., & Parker, L. A. (2013) · Annual Review of Psychology · doi:10.1146/annurev-psych-113011-143739 · Cited by 1,090
“However, Cippitelli et al. (2008) have reported an elevation of anandamide levels in rats with URB597, which was found to reduce anxiety associated with alcohol withdrawal.”
BackgroundEndocannabinoid signalling in reward and addiction
Parsons, L. H., & Hurd, Y. L. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn4004 · Cited by 481
Becker, J. A. J., Kieffer, B. L., & Le Merrer, J. (2017) · Addiction Biology · doi:10.1111/adb.12405 · Cited by 77
Jansma, J. M., van Hell, H. H., Vanderschuren, L. J. M. J., Bossong, M. G., Jager, G., Kahn, R. S., & Ramsey, N. F. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.6 · Cited by 58
“Functional mutations in the CB1 cannabinoid receptor and fatty acid amide hydrolyze genes (FAAH; the main enzyme that breaks down AEA) have been linked to rewarding effects of nicotine as well as other drugs such as cocaine, alcohol, marijuana and heroin.(10,37,41,42) Inhibition of FAAH with a selective inhibitor URB…”
BackgroundStopponi, S., Fotio, Y., Domi, A., Borruto, A. M., Natividad, L., Roberto, M., Ciccocioppo, R., & Cannella, N. (2018) · Addiction Biology · doi:10.1111/adb.12573 · Cited by 48
“…(number of open-arm entries/number of ‘open’ + ‘closed’ arm entries) × 100] are considered to be a reliable index of anxiety-like behavior, whereas the number of total arm entries was used as an index of generalized locomotor activity (Pellow et al. 1985; Cippitelli et al. 2011; Domi et al. 2016).”
MethodSelf-citation
Metadata
- Authors
- Cippitelli, A., Astarita, G., Duranti, A., Caprioli, G., Ubaldi, M., Stopponi, S., Kallupi, M., Sagratini, G., Rodrìguez de Fonseca, F., Piomelli, D., & Ciccocioppo, R.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-11-30
- Volume
- 6
- Issue
- 11
- Pages
- e28142
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2122938536
- Cited by
- 81
- References
- 25
- FWCI
- 3.96
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.